DORCHESTER WEALTH MANAGEMENT Co decreased its holdings in Nutrien Ltd (NYSE:NTR) by 10.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,132 shares of the company’s stock after selling 1,467 shares during the period. DORCHESTER WEALTH MANAGEMENT Co’s holdings in Nutrien were worth $605,000 as of its most recent SEC filing.
Several other institutional investors have also bought and sold shares of NTR. Cambiar Investors LLC bought a new stake in shares of Nutrien in the 2nd quarter worth $166,998,000. National Pension Service bought a new stake in shares of Nutrien in the 2nd quarter worth $69,931,000. Mackenzie Financial Corp increased its holdings in shares of Nutrien by 11.3% in the 2nd quarter. Mackenzie Financial Corp now owns 8,580,722 shares of the company’s stock worth $458,725,000 after purchasing an additional 872,389 shares in the last quarter. Nuveen Asset Management LLC bought a new stake in shares of Nutrien in the 2nd quarter worth $46,240,000. Finally, Beutel Goodman & Co Ltd. increased its holdings in shares of Nutrien by 5.7% in the 2nd quarter. Beutel Goodman & Co Ltd. now owns 13,435,410 shares of the company’s stock worth $718,661,000 after purchasing an additional 718,508 shares in the last quarter. 65.48% of the stock is owned by institutional investors and hedge funds.
NTR has been the subject of a number of research analyst reports. Raymond James reissued a “strong-buy” rating and issued a $70.00 target price on shares of Nutrien in a report on Tuesday, July 30th. Stifel Nicolaus reduced their target price on Nutrien from $63.00 to $62.00 and set a “buy” rating for the company in a report on Friday, October 4th. CIBC set a $70.00 target price on Nutrien and gave the stock a “buy” rating in a report on Wednesday, October 9th. Zacks Investment Research lowered Nutrien from a “hold” rating to a “sell” rating in a report on Wednesday, October 9th. Finally, Citigroup set a $61.00 target price on Nutrien and gave the stock a “buy” rating in a report on Wednesday, July 31st. One analyst has rated the stock with a sell rating, six have issued a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $61.87.
Nutrien (NYSE:NTR) last released its quarterly earnings results on Monday, July 29th. The company reported $1.58 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.59 by ($0.01). The firm had revenue of $8.66 billion during the quarter, compared to analysts’ expectations of $8.17 billion. Nutrien’s revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.48 EPS. Sell-side analysts expect that Nutrien Ltd will post 2.38 earnings per share for the current year.
The company also recently declared a quarterly dividend, which was paid on Thursday, October 17th. Stockholders of record on Monday, September 30th were paid a $0.45 dividend. This is an increase from Nutrien’s previous quarterly dividend of $0.43. This represents a $1.80 dividend on an annualized basis and a dividend yield of 3.67%. The ex-dividend date was Friday, September 27th. Nutrien’s dividend payout ratio (DPR) is 66.91%.
Nutrien Ltd. produces and markets crop nutrients to agricultural, industrial, and feed customers worldwide. It operates in four segments: Retail, Potash, Nitrogen, and Phosphate and Sulfate. The company offers potash, nitrogen, phosphate, and sulfate products. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through operating 1,700 retail locations.
Further Reading: Analyzing a company’s cash flow statement
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.